Sorrento Therapeutics, Inc. Stock
Stocks
SRNE
US83587F2020
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000600 USD | -14.29% |
|
-53.85% | -76.92% |
| 03-17 | Semnur Pharmaceuticals, Inc. Announces CEO Changes, Effective March 13, 2026 | CI |
| 03-17 | Semnur Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 67.15M 58.68M 54.25M 50.12M 94.38M 6.45B 96.09M 647M 254M 3.16B 252M 247M 10.87B | P/E 2021 |
-3.2x | P/E 2022 | -0.65x |
|---|---|---|---|---|---|
| Enterprise Value | 152M 133M 123M 113M 213M 14.57B 217M 1.46B 573M 7.13B 570M 557M 24.56B | EV / Sales 2021 |
29.1x | EV / Sales 2022 | 7.89x |
| Free-Float |
98.65% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -14.29% | ||
| 1 week | -53.85% | ||
| 1 month | -33.33% | ||
| 3 months | -25.00% | ||
| 6 months | -85.00% | ||
| Current year | -76.92% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.1 |
| 3 years | 0 | | 0.42 |
| 5 years | 0 | | 9.63 |
| 10 years | 0 | | 19.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 61 | 2011-03-31 |
Scott Schaus
CTO | Chief Tech/Sci/R&D Officer | - | 2022-02-28 |
John Waldheim
LAW | General Counsel | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Henry Ji
CHM | Chairman | 61 | 2017-07-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -14.29% | -53.85% | -53.85% | -99.83% | 326K | |
| -1.68% | -6.35% | +55.72% | +71.16% | 54.49B | |
| +6.05% | +7.79% | +62.23% | +88.46% | 55.93B | |
| -0.61% | -2.42% | +8.07% | +434.51% | 23.87B | |
| -0.29% | -4.13% | -18.56% | -16.48% | 22.86B | |
| +3.51% | +10.88% | +44.84% | -3.21% | 20B | |
| +1.18% | +0.21% | +39.31% | -29.41% | 17.48B | |
| -4.00% | -10.96% | +181.91% | +328.17% | 15.39B | |
| +7.69% | +11.91% | +50.03% | +720.96% | 15.19B | |
| -0.85% | -2.30% | +22.36% | +187.62% | 14.02B | |
| Average | -0.30% | -4.72% | +39.20% | +168.20% | 23.92B | |
| Weighted average by Cap. | +1.55% | +0.48% | +49.08% | +154.14% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 52.9M 46.23M 42.74M 39.49M 74.36M 5.08B 75.71M 510M 200M 2.49B 199M 194M 8.57B | 62.84M 54.92M 50.77M 46.9M 88.32M 6.04B 89.92M 605M 238M 2.96B 236M 231M 10.18B |
| Net income | -428M -374M -346M -320M -602M -41.14B -613M -4.13B -1.62B -20.15B -1.61B -1.57B -69.37B | -573M -501M -463M -428M -805M -55.02B -820M -5.52B -2.17B -26.94B -2.15B -2.1B -92.77B |
| Net Debt | 111M 96.74M 89.43M 82.62M 156M 10.63B 158M 1.07B 418M 5.21B 416M 407M 17.93B | 84.53M 73.87M 68.29M 63.09M 119M 8.12B 121M 814M 319M 3.98B 317M 310M 13.69B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-14 | US$0.000600 | -14.29% | 5,743 |
| 26-07-13 | US$0.000700 | 0.00% | 345,072 |
| 26-07-10 | US$0.000700 | -53.33% | 749,540 |
| 26-07-09 | US$0.001500 | +36.36% | 37,196 |
| 26-07-08 | US$0.001100 | -15.38% | 334,705 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SRNE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
